TIDMTYR 
 
RNS Number : 9636C 
TyraTech, Inc. 
24 November 2009 
 

+-------------------------------------------+-------------------------------------------+ 
| For immediate release                     |                          24 November 2009 | 
+-------------------------------------------+-------------------------------------------+ 
TYRATECH, INC. 
 
 
("TyraTech" or "the Company") 
 
 
Trading Update 
TyraTech, Inc. (AIM: TYR), a leading independent novel eco-technology company 
for human, animal and environmental health, reports that following a review of 
current trading, revenue expectations for the period ended 31 December 2009 are 
approximately US$6 million. The Company's cash position at the year end is 
expected to be approximately US$1.6 million. These changes are largely due to a 
disappointing performance from the Company's subsidiary Sustainable Solutions, 
which has continued to suffer from the poor performance of the US dairy market. 
In 2010 the Company will focus its resources on delivering near term revenue 
from existing partners. In order to exploit longer term opportunities, the 
Company is exploring financing options. 
TyraTech will provide a further update on trading and prospects in due course. 
For further information please contact: 
TyraTech Inc. 
Douglas Armstrong Ph.D., Chief Executive Officer    +1 (321) 409 7723 
Keith Bigsby, Chief Financial Officer                       +1 (321) 409 7714 
www.tyratech.com 
Nomura Code Securities 
Clare Terlouw / Chris Golden                                  +44 (0)20 7776 
1200 
www.nomuracode.com 
Buchanan Communications 
Lisa Baderoon/ Catherine Breen / Stasa Filiplic    +44 (0)20 7466 5000 
www.buchanan.uk.com 
 
 
About TyraTech 
TyraTech was formed in 2004 to develop and commercialise products for the 
control of invertebrate pests and pathogens using the Company's proprietary 
technology. TyraTech, which already has products on the market, is positioned 
for human health, animal health and pesticide market opportunities which total 
over $32 billion globally. TyraTech's Nature's Technology provides the Company 
with a wide variety of product and business opportunities in many markets and 
geographic regions. The differentiating feature of these products is the 
potential to have a combined level of potency and safety that other invertebrate 
control products are unable to offer. TyraTech's platform brings many of the 
principles of drug discovery and development to the fields of insecticides and 
parasiticides. By targeting specific chemoreceptors that are found in 
invertebrates but not in humans and animals, TyraTech can produce products that 
use natural plant derived compounds targeting these receptors. 
TyraTech's plan for the use of its technology is to develop selected proprietary 
active ingredients which can then be used across a wide variety of market 
segments, either by development partners or by TyraTech itself. TyraTech already 
has products or partnerships in the areas of professional and horticultural 
insect control, and for consumer and professional pest control. TyraTech also 
has an innovative partnership with Kraft to use its natural oils to develop 
functional foods for improving the health of the more than 2 billion people 
worldwide subject to intestinal parasitic infections. 
TyraTech also has a separate technology with associated intellectual property 
that is the basis for the Sustainable Solutions business. This technology has 
been incorporated into specialised dairy farm equipment for processing cattle 
manure waste to a usable material for TyraTech to sell as a commercial plant 
growing medium. For more information please visit www.tyratech.com. 
This announcement and the information contained herein includes forward-looking 
statements.  Forward-looking statements are identified by words such as 
"believe," "anticipate," "expect," "intend," "plan," "will," 
"may," "should," "could," "think," "estimate" and "predict," and 
other similar expressions. In addition, any statements that refer to 
expectations, projections or other characterisations of future events or 
circumstances are forward-looking statements. We based these forward-looking 
statements on our current expectations and projections about future events. Our 
actual results could differ materially from those discussed in, or implied by, 
these forward-looking statements. Factors that could cause actual results to 
differ from those implied by the forward-looking statements include a number of 
risks and uncertainties that are discussed in the section entitled "Risk 
Factors" in our Admission Document dated May 2007, which could have a material 
impact on the Company's long-term performance and prospects.  Forward-looking 
statements therefore speak only as of the date they are made and we assume no 
obligation to publicly update any of them in the light of new information or 
future events. 
 
 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTPUGMUGUPBPWW
Tyratech (LSE:TYR)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Tyratech Charts.
Tyratech (LSE:TYR)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Tyratech Charts.